Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 02/10 03:59:59 pm
81.73 USD   +1.98%
02/09 VERTEX PHARMACE : to Present at Upcoming Investor Conferences
02/08 VERTEX PHARMACE : FDA declines to approve Vertex's Kalydeco in peopl..
02/05 VERTEX PHARMACE : Receives Complete Response Letter from U.S. FDA fo..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/04/2016 02/05/2016 02/08/2016 02/09/2016 02/10/2016 Date
91.72(c) 86.61(c) 82(c) 80.14(c) 81.73 Last
2 452 985 4 571 268 4 215 071 4 159 543 4 115 154 Volume
-2.30% -5.57% -5.32% -2.27% +1.98% Change
More quotes
Financials ($)
Sales 2016 2 105 M
EBIT 2016 628 M
Net income 2016 360 M
Finance 2016 646 M
Yield 2016 -
Sales 2017 3 177 M
EBIT 2017 1 555 M
Net income 2017 1 070 M
Finance 2017 2 147 M
Yield 2017 -
P/E ratio 2016 71,51
P/E ratio 2017 19,42
EV / Sales 2016 9,05x
EV / Sales 2017 5,52x
Capitalization 19 692 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious... 
Sector
Biotechnology & Medical Research
Calendar
02/11 | 11:10amPresentation
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
02/09 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/08 VERTEX PHARMACEUTICALS : FDA declines to approve Vertex's Kalydeco in people wit..
02/05 VERTEX PHARMACEUTICALS : Receives Complete Response Letter from U.S. FDA for Use..
02/04 VERTEX PHARMACEUTICALS : Health Canada Approves PrORKAMBI® lumacaftor/ivacaftor ..
02/04 VERTEX PHARMACEUTICALS : Findings from Vertex Pharmaceuticals Inc. Reveals New F..
01/28DJU.S. HOT STOCKS : Hot Stocks to Watch
01/27 VERTEX PHARMACEUTICALS : 4Q tops expectations on strong Orkambi sales
01/27 VERTEX PHARMACEUTICALS : Reports Full-Year and Fourth Quarter 2015 Financial Res..
More news
Sector news : Bio Therapeutic Drugs
11:38a LONZA : and Renova Therapeutics Announce Manufacturing Agreement for Clinical Su..
05:04a PFIZER : Commends The FDA Advisory Committee's Vote To Approve Proposed Biosimil..
02/09DJPanel Recommends FDA Approval of Remicade Knockoff
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
02/08 Vertex Pharmaceuticals Has Great Upside Potential
02/06 INSIDERINSIGHTS.COM DAILY ROUND UP 2 : Cit, rit, tgi, bcrx
02/05 FDA rejects Vertex's application for expanded use of KALYDECO
02/02 Is The Biotech Sector Bottoming Out?
02/01 Vertex A Buy On Orkambi Revenue And Pipeline


Comments 
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions